Oxbridge Re Holdings supplied approximately $744,623 of the $781,767 raised by SurancePlus's two Solana-based placements, T20 and T42, leaving about $37,143 from third-party investors. Based on the reported total, that equates to roughly 95.25% parent-funded and 4.75% third-party-funded demand for the two products. Because Oxbridge consolidates SurancePlus, its 80%-owned tokenized reinsurance subsidiary, the parent-funded portion came from within the corporate group rather than independent investors. The same filing ties the T20 and T42 placements to a wider $7.1 million figure that also includes three HCI Group-linked securities. Those HCI-linked series generated $6.323 million in gross subscription proceeds, bringing the disclosed total to about $7.105 million, which rounds to the headline amount. But the filing identifies the buyers in those HCI-linked offerings only as "investors," without naming them or separating related-party from outside demand. That means the documents do not support treating the full $6.323 million as independently verified third-party demand. The filing also separates subscriptions from other funding measures. HCI, identified as a related entity through common directorship, contributed about $6.19 million in collateral to three trust accounts, while "the Company" deposited about $5.8 million in net HCI-token proceeds; the accounts held $12.02 million at June 30. HCI has described the tokens as synthetic contractual exposure, and the T20 and T42 instruments themselves grant contractual rights rather than equity ownership in SurancePlus. Their returns depend on allocated underwriting profits and can be reduced by losses on the underlying reinsurance contracts, leaving disclosed outside demand at about $37,143 for T20 and T42 and independent demand across the full $7.1 million unresolved.